C10023126 / invoice 10000
Species:CANINE
Breed:Labrador Retriever
Age (years):2
Diagnosis or signs:Consult and treatment
Consult notes
Appointment Notes: skin again, will collect zenrelia koSkin very inflamed/red raw currently. erythemic ventral abdomen, feet, axilla. Skin folds in axilla inflamed and "grey" hyperpigmented colourEars moderately waxy and inflamed. Plan -short course of cephalexin as suspicious secondary pyoderma axillamometamax ultra seems most effective for earsEars cleaned in consult and 0.8mL instilled both sidesCommence Zenrelia trial - 30mg sid x 30 days initially. (2 x 15mg tablets sid)Borderline dose range. Could try dropping to 1.5 tablets if doing well. Okay to collect more Zenrelia in next 6 months as needed.
Animal clinical history (3 most recent)
2026-03-12T00:00:00Z 5:10?pm
Appointment Notes: skin again, will collect zenrelia koSkin very inflamed/red raw currently. erythemic ventral abdomen, feet, axilla. Skin folds in axilla inflamed and "grey" hyperpigmented colourEars moderately waxy and inflamed. Plan -short course of cephalexin as suspicious secondary pyoderma axillamometamax ultra seems most effective for earsEars cleaned in consult and 0.8mL instilled both sidesCommence Zenrelia trial - 30mg sid x 30 days initially. (2 x 15mg tablets sid)Borderline dose range. Could try dropping to 1.5 tablets if doing well. Okay to collect more Zenrelia in next 6 months as needed. Vital Signs Weight: 37.4;
Previous claim history (13)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-01-21 | C09792425 | EAR INFECTION |
| 2025-12-29 | C09693113 | INTOXICATION (POISONING), PLANT - GRAPE/RAISIN |
| 2025-12-24 | C09672148 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2025-05-31 | C8784672 | PAIN - ABDOMINAL - PRESENTING COMPLAINT |
| 2025-05-08 | C8683971 | HYPERSENSITIVITY DISORDER (ALLERGY) |
| 2025-04-23 | C8618052 | ALLERGY |
| 2025-04-14 | C8585370 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2025-03-07 | C8506776 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2025-02-14 | C8347429 | HYPERSENSITIVITY DISORDER (ALLERGY) |
| 2025-01-08 | C8169640 | ANAL SAC DISORDER |
| 2025-01-08 | C8169640 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2024-12-12 | C8070080 | HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER |
| 2024-11-19 | C8070075 | VACCINATIONS OR HEALTH CHECKS |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_antibiotics_-_cephalexin | 101.40 | 2026-03-12 | — |
| 20000 | tstarc_food | 3.00 | 2026-03-12 | upstreamDSTP_general_exclusion |
| 30000 | tstarc_ear_medication_-_antibacterial_and_anti-fungal | 213.50 | 2026-03-12 | — |
| 40000 | tstarc_zenrelia_tablets | 250.50 | 2026-03-12 | — |
| 50000 | tstarc_consultation-revisit | 90.00 | 2026-03-12 | — |
UPM+
- DG02319HYPERSENSITIVITY (ALLERGIC) SKIN DISORDERDSTP_skin_-_allergic_disorder
- DG00676EAR (AURAL) INFECTIONDSTP_otitis_externa
Variant (sleepy_king)
HYPERSENSITIVITY DISORDER (ALLERGY)
DSTP_skin_-_allergic_disorder
Conf: 0.460
Threshold: 0.38
Above: ✓
Correct?